Related Experiment Videos
Retinal complications with elevated circulating plasma C5a associated with interferon-alpha therapy for chronic
S Sugano1, M Yanagimoto, T Suzuki
1Saiseikai Wakakusa Hospital, Yokohama, Japan.
The American Journal of Gastroenterology
|November 1, 1994
Summary
Interferon-alpha therapy can cause retinal hemorrhage by activating complement 5, leading to capillary damage. Monitoring activated complement 5 may predict this serious complication in patients.
Area of Science:
- Ophthalmology
- Immunology
- Hepatology
Background:
- Retinal hemorrhage is an adverse event linked to interferon therapy.
- The pathogenesis of this complication remains unclear.
- Interferon-alpha is a treatment for chronic active hepatitis C.
Observation:
- Two patients with chronic active hepatitis C developed retinal hemorrhage or cotton wool patches during interferon-alpha treatment.
- Elevated plasma-activated complement 5 levels were observed during the episodes.
- Activated complement 5 levels decreased as the retinal conditions resolved.
Findings:
- Interferon-alpha therapy can activate the complement system.
- Activated complement 5 appears to play a role in retinal capillary infarction.
- Elevated activated complement 5 levels correlate with retinal hemorrhage development.
Implications:
- Activated complement 5 may be a biomarker for predicting retinal artery infarction.
- This finding suggests a potential mechanism for interferon-induced retinal vascular events.
- Further research could explore the role of complement activation in other interferon-related toxicities.